Gucalp, A., Sparano, J. A., Caravelli, J., Santamauro, J., Patil, S., Abbruzzi, A., . . . Traina, T. A. (2011). Phase II trial of saracatinib (AZD0530), an oral src-inhibitor for the treatment of patients with hormone receptor negative metastatic breast cancer.
Styl ChicagoGucalp, Ayca, et al. Phase II Trial of Saracatinib (AZD0530), an Oral Src-inhibitor for the Treatment of Patients With Hormone Receptor Negative Metastatic Breast Cancer. 2011.
Citace podle MLAGucalp, Ayca, et al. Phase II Trial of Saracatinib (AZD0530), an Oral Src-inhibitor for the Treatment of Patients With Hormone Receptor Negative Metastatic Breast Cancer. 2011.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..